Multifrequency MRE in Evaluation of Chronic Kidney Diseases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multifrequency MRE in Evaluation of Chronic Kidney Diseases — Stella

Home/Chronic Kidney Disease (CKD)/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Kidney Disease (CKD) trials

Trial locations(1 site)

China

Shengjing Hospital of China Medical University, Shenyang, Liaoning

Key details

Sponsor

Shengjing Hospital

Enrollment target

~200 participants

Started

October 2022

Primary completion

June 2027

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.